Burning Rock Biotech Limited's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 2.93, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Burning Rock Biotech Limited in Dec 31 2025 quarter, has decreased to 125 days, compared to 129 days, in the 0 quarter.

If we take a look into Healthcare sector 223 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1829, from overall ranking in the third quarter 2025 at 1858.

What is Receivable Turnover Ratio?
What is Burning Rock Biotech Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BNR Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	20.72 %	16.46 %	16.46 %	16.46 %	16.47 %
Y / Y Revenue Change	9.18 %	-	-	-	-6.64 %
Receivable Turnover Ratio (TTM)	2.93	2.83	2.93	3.04	3.16
BNR's Total Ranking	# 1829	# 1858	#	#	#
Accounts Receivable average collection period days	125	129	125	120	116
Seq. Receivable Change	34.93 %	0 %	0 %	-10.53 %	30.17 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 17
Healthcare Sector	# 224
Overall Market	# 1829

Receivable Turnover Ratio Statistics
High	Average	Low
0.66	0.47	0.22
(Dec 31 2025)		(Dec 31 2021)

BNR Company Profile • Back to BNR Efficiency Comparisons • Compare BNR Receivables Turnover Ratio to its Competitors

Financial Statements
Burning Rock Biotech Limited's Accounts Receivable	$ 33 Millions	Visit BNR's Balance sheet
Burning Rock Biotech Limited's Sales TTM	$ 77 Millions	Visit BNR's Income Statement
Sources of BNR's Revenues		Visit BNR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BNR's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BNR's Growth Rates	BNR's Roa	BNR's Inventory Turnover Ratio	BNR's Dividend Comparisons
BNR's Profitability Ratios	BNR's Roi	BNR's Asset Turnover Ratio	BNR's Dividend Growth
BNR's Valuation Ratios	BNR's Roe	BNR's Financial Strength Ratios	BNR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Haemonetics Corporation	6.48	$ 1,317.424 Millions	$ 203.283 Millions
Nano X Imaging Ltd	6.47	$ 13.021 Millions	$ 2.013 Millions
Pulmonx Corporation	6.47	$ 90.139 Millions	$ 13.937 Millions
Zoetis Inc	6.46	$ 9,445.000 Millions	$ 1,462.750 Millions
Stryker Corp	6.46	$ 25,116.000 Millions	$ 3,890.250 Millions
Stereotaxis Inc	6.45	$ 32.071 Millions	$ 4.974 Millions
Cvrx inc	6.43	$ 56.340 Millions	$ 8.760 Millions
Harvard Bioscience Inc	6.42	$ 85.910 Millions	$ 13.392 Millions
Intellia Therapeutics Inc	6.39	$ 67.671 Millions	$ 10.594 Millions
Opko Health Inc	6.38	$ 606.879 Millions	$ 95.090 Millions
Lakeland Industries Inc	6.37	$ 192.648 Millions	$ 30.221 Millions
Bruker Corporation	6.37	$ 3,435.700 Millions	$ 539.050 Millions
Baxter International Inc	6.37	$ 11,244.000 Millions	$ 1,764.250 Millions
Catalyst Pharmaceuticals Inc	6.37	$ 588.989 Millions	$ 92.504 Millions
Novartis Ag	6.34	$ 56,674.000 Millions	$ 8,937.000 Millions
Pacira Biosciences inc	6.34	$ 726.411 Millions	$ 114.612 Millions
Ardelyx inc	6.33	$ 407.320 Millions	$ 64.370 Millions
Adm Tronics Unlimited Inc	6.31	$ 3.414 Millions	$ 0.541 Millions
Anaptysbio Inc	6.30	$ 234.603 Millions	$ 37.209 Millions
Seastar Medical Holding Corp	6.29	$ 1.234 Millions	$ 0.196 Millions
Envoy Medical Inc	6.26	$ 0.241 Millions	$ 0.039 Millions
Liquidia Corporation	6.25	$ 158.320 Millions	$ 25.317 Millions
Elutia Inc	6.25	$ 17.639 Millions	$ 2.824 Millions
Star Equity Holdings Inc	6.24	$ 141.384 Millions	$ 22.646 Millions
Vertex Pharmaceuticals Inc	6.24	$ 12,001.300 Millions	$ 1,924.450 Millions
Treace Medical Concepts Inc	6.23	$ 212.690 Millions	$ 34.139 Millions
Telix Pharmaceuticals Ltd	6.22	$ 803.794 Millions	$ 129.202 Millions
Select Medical Holdings Corp	6.22	$ 5,452.830 Millions	$ 876.916 Millions
Strata Critical Medical Inc	6.17	$ 197.126 Millions	$ 31.949 Millions
Nuwellis Inc	6.16	$ 8.270 Millions	$ 1.342 Millions

Date modified: 2026-10-05T11:03:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.